CFGS
AZN icon

Concourse Financial Group Securities’s AstraZeneca AZN Stock Holding History

Concourse Financial Group Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,976
Closed -$1.91M – 165
2024
Q4 		$1.91M Buy
13,976
+1,325
+10% +$186K 0.11% 193
2024
Q3 		$1.97M Buy
12,651
+2,129
+20% +$344K 0.12% 178
2024
Q2 		$1.64M Buy
10,522
+654
+7% +$98.4K 0.1% 204
2024
Q1 		$1.34M Buy
9,868
+458
+5% +$60.6K 0.09% 236
2023
Q4 		$1.27M Buy
9,410
+3,532
+60% +$459K 0.09% 227
2023
Q3 		$796K Sell
5,878
-153
-3% -$20.9K 0.06% 315
2023
Q2 		$863K Buy
6,031
+416
+7% +$61.2K 0.07% 308
2023
Q1 		$779K Buy
5,615
+4,999
+812% +$673K 0.06% 325
2022
Q4 		$83.5K Buy
616
+5
+0.8% +$627 0.01% 891
2022
Q3 		$67K Buy
611
+8
+1% +$1.01K 0.01% 851
2022
Q2 		$80K Sell
603
-177
-23% -$23.2K 0.01% 901
2022
Q1 		$104K Sell
780
-1,299
-62% -$156K 0.01% 845
2021
Q4 		$242K Buy
2,079
+38
+2% +$4.47K 0.01% 664
2021
Q3 		$245K Buy
2,041
+111
+6% +$12.9K 0.02% 651
2021
Q2 		$231K Sell
1,930
-84
-4% -$9.22K 0.01% 668
2021
Q1 		$200K Buy
2,014
+1,565
+349% +$157K 0.01% 688
2020
Q4 		$45K Sell
449
-32
-7% -$3.39K ﹤0.01% 1185
2020
Q3 		$53K Buy
481
+17
+4% +$1.89K ﹤0.01% 1035
2020
Q2 		$49K Buy
464
+26
+6% +$2.69K ﹤0.01% 997
2020
Q1 		$39K Buy
+438
New +$41.2K ﹤0.01% 999
2019
Q2 		– Sell
-981
Closed -$76.9K – 2240
2019
Q1 		$79K Buy
981
+112
+13% +$8.83K 0.01% 737
2018
Q4 		$66K Buy
869
+280
+48% +$21.9K 0.01% 728
2018
Q3 		$47K Buy
+589
New +$44.5K 0.01% 606

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Concourse Financial Group Securities's AZN Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of AstraZeneca (AZN) in Q1 2025, closing a stake of 13,976 shares — an estimated $1.91M sold.

Concourse Financial Group Securities first reported a position in AZN in Q3 2018 and held it in 23 quarters. The position peaked at $1.97M in Q3 2024. 1,250 funds tracked by Wall St. Rank hold AZN as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining AstraZeneca position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 13,976 AstraZeneca shares in Q1 2025, an estimated $1.91M.
  • Concourse Financial Group Securities first reported a position in AstraZeneca in Q3 2018 and held it in 23 quarters.
  • Concourse Financial Group Securities's AstraZeneca position peaked at $1.97M in Q3 2024.
  • 1,250 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.